Clinical trial
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
NCT00162695 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Terminated
Key facts
| NCT number | NCT00162695 |
|---|---|
| Title | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhabdomyosarcoma, Malignant Soft Tissue |
| Intervention type | Drug |
| Interventions | Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide |
| Enrollment | 400 |
| Start date | Jul 1, 1995 |
| First posted | Sep 13, 2005 |
| Last update posted | Sep 13, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: